Development of a Therapeutic Respiratory THC Dry Powder Inhaler
ARE Labs has been recently granted a Schedule 1 Research Drug License approved by DEA, NIH/NIDA & FDA for research into the feasibility of delivery of THC and THC-CBD via [...]
ARE Labs has been recently granted a Schedule 1 Research Drug License approved by DEA, NIH/NIDA & FDA for research into the feasibility of delivery of THC and THC-CBD via [...]